Ian Clements Net Worth & Insider Trades

Ian Clements - Chief Financial Officer, Mirum Pharmaceuticals, Inc

As of November 14, 2022

What is Ian Clements's Net Worth?

The current estimated net worth of Mirum Pharmaceuticals, Inc's Chief Financial Officer, Ian Clements, is estimated to be about $135.53K . Ian Clements owns about 18,561 units of Mirum Pharmaceuticals, Inc common stock. In the last 3 years at Mirum Pharmaceuticals, Inc, Ian Clements has sold an estimated value of $30.31K worth.

What is Ian Clements's Past Insider Trading?

Ian Clements's largest purchase order was 4,000 units , worth over $46.04K on September 10, 2019. Ian Clements's largest sale order was 1,574 units , worth over $30.31K on October 1, 2021. In total, Ian Clements has made about 12 transactions over 3 years of their time at Mirum Pharmaceuticals, Inc. Ian Clements usually trades in November, with the busiest year in 2021. The most recent transaction was a purchase order of 1,450 units , worth over $20.5K on November 29, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Ian Clements's Salary in 2020?

As Chief Financial Officer of Mirum Pharmaceuticals, Inc, Ian Clements has a total base salary of $378,390 . Ian Clements received compensation valued at about $1,389,494 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of a bonus of $151,356 , option awards of $848,348 , and other compensation of $11,400 .

What is Ian Clements's' Mailing Address?

  • Mailing address is C/o Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 CA

Mirum Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Christopher Peetz 2020 $511,818 $265,952 $2,218,755 $7,453 $3,003,978
Christopher Peetz 2019 $457,614 $286,100 $5,491,471 - $6,235,185
Peter Radovich 2020 $277,992 $111,197 $2,255,631 - $2,644,820
Ian Clements, Ph.D. 2020 $378,390 $151,356 $848,348 $11,400 $1,389,494
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1759425/000119312521116249/d352758ddef14a.htm

What are Mirum Pharmaceuticals, Inc's Past Insider Trades?

Mirum Pharmaceuticals, Inc's most recent insider trade came on November 15, 2022 by Niall O'Donnell Attorney-In-Fact who sold 300,000 units worth $5.96M . In the last 3 years, insiders at Mirum Pharmaceuticals, Inc have sold an estimated value of $9.77M and bought an estimated value of $113.84M worth of shares. Insider trading is most common in June, with the busiest year in 2021. The most active traders at the company are Ian Clements, Chief Financial Officer,  Christopher Peetz, President and CEO,  and Jonathan Edwin Tucker, Chief Medical Officer .

Mirum Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1